These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27476612)

  • 1. Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a "TRAP" to increase levels of TIMP-3 in the tissue.
    Scilabra SD; Yamamoto K; Pigoni M; Sakamoto K; Müller SA; Papadopoulou A; Lichtenthaler SF; Troeberg L; Nagase H; Kadomatsu K
    Matrix Biol; 2017 May; 59():69-79. PubMed ID: 27476612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1.
    Carreca AP; Pravatà VM; Markham M; Bonelli S; Murphy G; Nagase H; Troeberg L; Scilabra SD
    Sci Rep; 2020 Jul; 10(1):12067. PubMed ID: 32694578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1.
    Scilabra SD; Troeberg L; Yamamoto K; Emonard H; Thøgersen I; Enghild JJ; Strickland DK; Nagase H
    J Biol Chem; 2013 Jan; 288(1):332-42. PubMed ID: 23166318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.
    Scilabra SD; Pigoni M; Pravatá V; Schätzl T; Müller SA; Troeberg L; Lichtenthaler SF
    Sci Rep; 2018 Oct; 8(1):14697. PubMed ID: 30279425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated glycosaminoglycans control the extracellular trafficking and the activity of the metalloprotease inhibitor TIMP-3.
    Troeberg L; Lazenbatt C; Anower-E-Khuda MF; Freeman C; Federov O; Habuchi H; Habuchi O; Kimata K; Nagase H
    Chem Biol; 2014 Oct; 21(10):1300-1309. PubMed ID: 25176127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity.
    Doherty CM; Visse R; Dinakarpandian D; Strickland DK; Nagase H; Troeberg L
    J Biol Chem; 2016 Oct; 291(42):22160-22172. PubMed ID: 27582494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1.
    Yamamoto K; Okano H; Miyagawa W; Visse R; Shitomi Y; Santamaria S; Dudhia J; Troeberg L; Strickland DK; Hirohata S; Nagase H
    Matrix Biol; 2016 Dec; 56():57-73. PubMed ID: 27084377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities.
    Thevenard J; Verzeaux L; Devy J; Etique N; Jeanne A; Schneider C; Hachet C; Ferracci G; David M; Martiny L; Charpentier E; Khrestchatisky M; Rivera S; Dedieu S; Emonard H
    PLoS One; 2014; 9(7):e103839. PubMed ID: 25075518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism.
    Emonard H; Bellon G; Troeberg L; Berton A; Robinet A; Henriet P; Marbaix E; Kirkegaard K; Patthy L; Eeckhout Y; Nagase H; Hornebeck W; Courtoy PJ
    J Biol Chem; 2004 Dec; 279(52):54944-51. PubMed ID: 15489233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin Inhibits Osteoarthritic Cartilage Degradation by Increasing Extracellular Levels of Chondroprotective Tissue Inhibitor of Metalloproteinases 3.
    Chanalaris A; Doherty C; Marsden BD; Bambridge G; Wren SP; Nagase H; Troeberg L
    Mol Pharmacol; 2017 Oct; 92(4):459-468. PubMed ID: 28798097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein.
    Cam JA; Zerbinatti CV; Li Y; Bu G
    J Biol Chem; 2005 Apr; 280(15):15464-70. PubMed ID: 15705569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
    Troeberg L; Fushimi K; Scilabra SD; Nakamura H; Dive V; Thøgersen IB; Enghild JJ; Nagase H
    Matrix Biol; 2009 Oct; 28(8):463-9. PubMed ID: 19643179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.
    Rother S; Samsonov SA; Hofmann T; Blaszkiewicz J; Köhling S; Moeller S; Schnabelrauch M; Rademann J; Kalkhof S; von Bergen M; Pisabarro MT; Scharnweber D; Hintze V
    Acta Biomater; 2016 Nov; 45():143-154. PubMed ID: 27545813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated Hyaluronan Alters the Interaction Profile of TIMP-3 with the Endocytic Receptor LRP-1 Clusters II and IV and Increases the Extracellular TIMP-3 Level of Human Bone Marrow Stromal Cells.
    Rother S; Samsonov SA; Hempel U; Vogel S; Moeller S; Blaszkiewicz J; Köhling S; Schnabelrauch M; Rademann J; Pisabarro MT; Hintze V; Scharnweber D
    Biomacromolecules; 2016 Oct; 17(10):3252-3261. PubMed ID: 27610455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1.
    Lee MH; Atkinson S; Murphy G
    J Biol Chem; 2007 Mar; 282(9):6887-98. PubMed ID: 17202148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.
    Selvais C; D'Auria L; Tyteca D; Perrot G; Lemoine P; Troeberg L; Dedieu S; Noël A; Nagase H; Henriet P; Courtoy PJ; Marbaix E; Emonard H
    FASEB J; 2011 Aug; 25(8):2770-81. PubMed ID: 21518850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway.
    Melman L; Geuze HJ; Li Y; McCormick LM; Van Kerkhof P; Strous GJ; Schwartz AL; Bu G
    Mol Biol Cell; 2002 Sep; 13(9):3325-35. PubMed ID: 12221136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
    J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation.
    Selvais C; Gaide Chevronnay HP; Lemoine P; Dedieu S; Henriet P; Courtoy PJ; Marbaix E; Emonard H
    Endocrinology; 2009 Aug; 150(8):3792-9. PubMed ID: 19406945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65.
    Kinoshita A; Whelan CM; Smith CJ; Mikhailenko I; Rebeck GW; Strickland DK; Hyman BT
    J Neurosci; 2001 Nov; 21(21):8354-61. PubMed ID: 11606623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.